Related Experiment Video
Updated: Jun 21, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after
Noemi Rovaris Gardinali1, Juliana Rodrigues Guimarães1, Juliana Gil Melgaço1
1Laboratório de Desenvolvimento Tecnológico em Virologia, Oswaldo Cruz, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Abstract:
Epidemiological studies found that hepatitis E virus genotype 3 (HEV-3) infection was associated with chronic hepatitis and cirrhosis in immunocompromised patients. Our study aimed to investigate the relationship between the host immunosuppressive status and the occurrence of HEV-related chronic hepatitis. Here we describe a successful experimental study, using cynomolgus monkeys previously treated with tacrolimus, a potent calcineurin inhibitor immunosuppressant, and infected with a Brazilian HEV-3 strain isolated from naturally infected pigs. HEV infected monkeys were followed up during 160 days post infection (dpi) by clinical signs; virological, biochemical and haematological parameters; and liver histopathology. The tacrolimus blood levels were monitored throughout the experiment. Immunosuppression was confirmed by clinical and laboratorial findings, such as: moderate weight loss, alopecia, and herpes virus opportunistic infection. In this study, chronic HEV infection was characterized by the mild increase of liver enzymes serum levels; persistent RNA viremia and viral faecal shedding; and liver histopathology. Three out of four immunosuppressed monkeys showed recurrent HEV RNA detection in liver samples, evident hepatocellular ballooning degeneration, mild to severe macro and microvesicular steatosis (zone 1), scattered hepatocellular apoptosis, and lobular focal inflammation. At 69 dpi, liver biopsies of all infected monkeys revealed evident ballooning degeneration (zone 3), discrete hepatocellular apoptosis, and at most mild portal and intra-acinar focal inflammation. At 160 dpi, the three chronically HEV infected monkeys showed microscopic features (piecemeal necrosis) corresponding to chronic hepatitis in absence of fibrosis and cirrhosis in liver parenchyma. Within 4-months follow up, the tacrolimus-immunosuppressed cynomolgus monkeys infected with a Brazilian swine HEV-3 strain exhibited more severe hepatic lesions progressing to chronic hepatitis without liver fibrosis, similarly as shown in tacrolimus-immunosuppressed solid organ transplant (SOT) recipients. The cause-effect relationship between HEV infection and tacrolimus treatment was confirmed in this experiment.
Insights
Hepatitis E virus genotype 3 (HEV-3) infection in immunosuppressed monkeys led to chronic hepatitis. Tacrolimus treatment exacerbated HEV-3 infection, causing liver damage without fibrosis, mimicking outcomes in human transplant recipients.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis E virus genotype 3 (HEV-3) infection is linked to chronic hepatitis and cirrhosis in immunocompromised individuals.
- The role of host immunosuppressive status in the development of HEV-related chronic hepatitis requires further investigation.
Purpose of the Study:
- To investigate the relationship between immunosuppression induced by tacrolimus and the occurrence of HEV-3 related chronic hepatitis.
- To establish a cause-effect relationship between HEV infection and tacrolimus treatment in a primate model.
Main Methods:
- Cynomolgus monkeys were treated with tacrolimus to induce immunosuppression and subsequently infected with a Brazilian HEV-3 strain.
- Monkeys were monitored for 160 days, assessing clinical signs, virological, biochemical, haematological parameters, and liver histopathology.
- Tacrolimus blood levels were monitored to confirm sustained immunosuppression.
Main Results:
- Immunosuppression was confirmed by clinical and laboratory findings, including opportunistic infections.
- Chronic HEV infection was characterized by persistent viremia, viral shedding, and mild liver enzyme elevation.
- Three out of four immunosuppressed monkeys developed chronic hepatitis with significant hepatocellular damage, steatosis, and inflammation, but without fibrosis or cirrhosis.
Conclusions:
- Tacrolimus-immunosuppressed cynomolgus monkeys infected with HEV-3 exhibited severe hepatic lesions progressing to chronic hepatitis without fibrosis.
- These findings mimic the liver pathology observed in tacrolimus-immunosuppressed solid organ transplant recipients.
- The study confirmed a cause-effect relationship between HEV infection and tacrolimus treatment in this experimental model.
Related Concept Videos
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

